Responses of human synovial fibroblasts to mononuclear cell factors and retinoic acid.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D003470:Culture Media; D000242:Cyclic AMP / Q000502:physiology; D015232:Dinoprostone; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D006820:Hyaluronic Acid / Q000378:metabolism; D007213:Indomethacin / Q000494:pharmacology; D008247:Lysosomes / Q000201:enzymology; D003012:Microbial Collagenase / Q000378:metabolism; D015846:Monokines; D010960:Plasminogen Activators / Q000378:metabolism*; D011458:Prostaglandins E / Q000494:pharmacology; D014176:Protein Biosynthesis; D011506:Proteins / Q000494:pharmacology*; D012313:RNA / Q000096:biosynthesis; D013583:Synovial Membrane / Q000166:cytology / Q000201:enzymology*; D014212:Tretinoin / Q000494:pharmacology*
D003470:Culture Media; D005938:Glucocorticoids; D015846:Monokines; D011458:Prostaglandins E; D011506:Proteins; D014212:Tretinoin; D012313:RNA; D006820:Hyaluronic Acid; D000242:Cyclic AMP; D010960:Plasminogen Activators; D003012:Microbial Collagenase; D015232:Dinoprostone; D015056:1-Methyl-3-isobutylxanthine; D007213:Indomethacin